NCT06448611View on ClinicalTrials.gov

Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2027

Conditions
Merkel Cell Carcinoma
Interventions
OTHER

Blood Test

Research and quantification of Circulating Tumor Cells

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT06448611 - Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma | Biotech Hunter | Biotech Hunter